ZA200205145B - Thienopyridine derivatives, their production and use. - Google Patents

Thienopyridine derivatives, their production and use. Download PDF

Info

Publication number
ZA200205145B
ZA200205145B ZA200205145A ZA200205145A ZA200205145B ZA 200205145 B ZA200205145 B ZA 200205145B ZA 200205145 A ZA200205145 A ZA 200205145A ZA 200205145 A ZA200205145 A ZA 200205145A ZA 200205145 B ZA200205145 B ZA 200205145B
Authority
ZA
South Africa
Prior art keywords
optionally substituted
group
salt
optionally
ring
Prior art date
Application number
ZA200205145A
Other languages
English (en)
Inventor
Tsuneo Yasuma
Atsuo Baba
Haruhiko Makino
Isao Aoki
Toshiaki Nagata
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of ZA200205145B publication Critical patent/ZA200205145B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA200205145A 2000-02-29 2002-06-26 Thienopyridine derivatives, their production and use. ZA200205145B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000105770 2000-02-29

Publications (1)

Publication Number Publication Date
ZA200205145B true ZA200205145B (en) 2003-09-04

Family

ID=18619051

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200205145A ZA200205145B (en) 2000-02-29 2002-06-26 Thienopyridine derivatives, their production and use.

Country Status (28)

Country Link
US (2) US6653476B2 (cs)
EP (1) EP1259515B1 (cs)
JP (1) JP3917821B2 (cs)
KR (1) KR100780584B1 (cs)
CN (1) CN1326859C (cs)
AR (1) AR028511A1 (cs)
AT (1) ATE282042T1 (cs)
AU (1) AU2001235985A1 (cs)
BR (1) BR0108840A (cs)
CA (1) CA2397165A1 (cs)
CZ (1) CZ20022511A3 (cs)
DE (1) DE60107055T2 (cs)
DK (1) DK1259515T3 (cs)
ES (1) ES2227139T3 (cs)
HK (1) HK1048120B (cs)
HU (1) HUP0300028A3 (cs)
IL (1) IL151082A0 (cs)
MX (1) MXPA02008414A (cs)
NO (1) NO20024107L (cs)
NZ (1) NZ520155A (cs)
PL (1) PL358015A1 (cs)
PT (1) PT1259515E (cs)
RU (1) RU2002125854A (cs)
SI (1) SI1259515T1 (cs)
SK (1) SK10712002A3 (cs)
TW (1) TW591031B (cs)
WO (1) WO2001064685A2 (cs)
ZA (1) ZA200205145B (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW591031B (en) * 2000-02-29 2004-06-11 Takeda Chemical Industries Ltd Thienopyridine derivatives, their production and use
US7644057B2 (en) * 2001-01-03 2010-01-05 International Business Machines Corporation System and method for electronic communication management
WO2003018590A1 (fr) * 2001-08-24 2003-03-06 Takeda Chemical Industries, Ltd. Procede de production d'un derive de la thienopyridine
CA2466870A1 (en) * 2001-11-26 2003-06-05 Trustees Of Tufts College Methods for treating autoimmune disorders, and reagents related thereto
MY151015A (en) * 2004-05-14 2014-03-31 Takeda Pharmaceutical Thienopyridine derivative, production method and use thereof
CA2591211A1 (en) * 2004-12-17 2006-06-22 Parichehr Malherbe Thieno-pyridine derivatives as gaba-b allosteric enhancers
EP1971595B1 (en) * 2005-12-30 2013-10-16 Merck Sharp & Dohme Corp. Cetp inhibitors
WO2013072882A1 (en) 2011-11-18 2013-05-23 Actelion Pharmaceuticals Ltd 2 -amino- 1, 8 -naphthyridine-3 -carboxamide derivatives as antimicrobial agents

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0791000B1 (en) * 1994-11-08 2002-10-02 Takeda Chemical Industries, Ltd. Thienopyridine or thienopyrimidine derivatives and their use
US5620997A (en) * 1995-05-31 1997-04-15 Warner-Lambert Company Isothiazolones
PL329308A1 (en) * 1996-04-13 1999-03-15 Astra Pharma Prod Derivatives of aminoisoquinoline and aminothienepyridine as well as their application as antinflammatory agents
EP0900223A1 (en) 1996-04-25 1999-03-10 Takeda Chemical Industries, Ltd. Thienopyridine derivatives and their use
WO1999065916A1 (en) 1998-06-15 1999-12-23 Takeda Chemical Industries, Ltd. Thienodipyridine derivatives, production and use thereof
TW591031B (en) * 2000-02-29 2004-06-11 Takeda Chemical Industries Ltd Thienopyridine derivatives, their production and use

Also Published As

Publication number Publication date
EP1259515B1 (en) 2004-11-10
CA2397165A1 (en) 2001-09-07
IL151082A0 (en) 2003-04-10
ATE282042T1 (de) 2004-11-15
DE60107055T2 (de) 2005-11-03
DE60107055D1 (de) 2004-12-16
TW591031B (en) 2004-06-11
NO20024107L (no) 2002-09-27
KR100780584B1 (ko) 2007-11-29
HUP0300028A3 (en) 2004-10-28
MXPA02008414A (es) 2003-02-12
US7067527B2 (en) 2006-06-27
PL358015A1 (en) 2004-08-09
RU2002125854A (ru) 2004-01-10
NZ520155A (en) 2003-06-30
US20030130517A1 (en) 2003-07-10
US20040054183A1 (en) 2004-03-18
BR0108840A (pt) 2002-12-17
AU2001235985A1 (en) 2001-09-12
CN1411461A (zh) 2003-04-16
HK1048120A1 (en) 2003-03-21
HUP0300028A2 (en) 2003-05-28
CZ20022511A3 (cs) 2003-02-12
US6653476B2 (en) 2003-11-25
CN1326859C (zh) 2007-07-18
WO2001064685A2 (en) 2001-09-07
DK1259515T3 (da) 2005-01-31
WO2001064685A3 (en) 2002-08-08
SI1259515T1 (en) 2005-04-30
HK1048120B (en) 2005-05-06
AR028511A1 (es) 2003-05-14
JP2001316390A (ja) 2001-11-13
JP3917821B2 (ja) 2007-05-23
PT1259515E (pt) 2005-02-28
EP1259515A2 (en) 2002-11-27
NO20024107D0 (no) 2002-08-28
KR20020075442A (ko) 2002-10-04
ES2227139T3 (es) 2005-04-01
SK10712002A3 (sk) 2003-02-04

Similar Documents

Publication Publication Date Title
US20240400586A1 (en) Heteroaryl derivative parp inhibitor and use thereof
TWI862645B (zh) 腺苷衍生物及包含其之醫藥組合物
JP3420751B2 (ja) 選択的ｃｏｘ‐２インヒビターとしてのピラゾロピリジン誘導体
ES2425739T3 (es) Sorafenib-tosilato para el tratamiento de enfermedades caracterizadas por angiogénesis anormal
ES2469849T3 (es) Derivados deuterados de isoindolin-1,3-diona como inhibidores de PDE4 y TNF-alfa
AU2017252640A1 (en) NLRP3 modulators
IL139200A (en) GASTRIC ACID SECRETION INHIBITING (N - SUBSTITUTED) IMIDAZO [1,2 - a] PYRIDINE - 6 - CARBOXAMIDES CARRYING A BENZYL GROUP IN POSITION 8, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND SOME INTERMEDIATES THEREFOR
AU775993B2 (en) Imidazopyridine derivatives as phosphodiesterase VII inhibitors
KR20170105119A (ko) 치환된 이미다조[1,2-a]피리딘-2-일아민 화합물, 및 약학 조성물 및 이의 사용 방법
JP7626721B2 (ja) 小分子標的ブロモ／アセチルタンパク質およびその使用
CA3217763A1 (en) Tricyclic ubiquitin specific protease 1 inhibitor and use thereof
ZA200100913B (en) New compounds.
ZA200205145B (en) Thienopyridine derivatives, their production and use.
TW202115083A (zh) 肽醯精胺酸脫亞胺酶抑制劑及其用途
WO2020150115A1 (en) Nlrp3 modulators
RU2294935C2 (ru) Имидазопиридиновые производные для применения в терапии в качестве лекарственного средства, ингибирующего протонный насос, и промежуточные соединения для их получения
EA036965B1 (ru) Ингибиторы деацетилаз гистонов и композиции и способы их применения
TW200808317A (en) Compounds for treating pulmonary hypertension
WO2022079246A1 (en) Nlrp3 activators for use in the treatment of infectious diseases or cancer by activating nlrp3 inflammasome
CN113747894B (zh) 成纤维细胞生长因子受体2(fgfr2)的降解剂
CA2694994C (fr) Derives de n-heteroaryl-carboxamides tricycliques, leur preparation et leur application en therapeutique
JPH04173791A (ja) 循環器系疾患の予防及び治療剤
CN115304597B (zh) 一类β-咔啉类化合物及其在制备治疗或预防肿瘤疾病的药物中的应用
AU2005289599A1 (en) Crytalline forms of a pyrazolo [3, 4-c ] pyridine factor Xa inhibitor
WO2000068231A1 (fr) Dihydrate derive de purine, medicaments le contenant comme principe actif et intermediaire utilise dans sa preparation